MA47027B1 - Compositions et procédés non hormonaux pour la contraception masculine avec (r)-silodosin - Google Patents
Compositions et procédés non hormonaux pour la contraception masculine avec (r)-silodosinInfo
- Publication number
- MA47027B1 MA47027B1 MA47027A MA47027A MA47027B1 MA 47027 B1 MA47027 B1 MA 47027B1 MA 47027 A MA47027 A MA 47027A MA 47027 A MA47027 A MA 47027A MA 47027 B1 MA47027 B1 MA 47027B1
- Authority
- MA
- Morocco
- Prior art keywords
- contraception
- composition
- present
- silodosin
- methods
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 3
- 229960004953 silodosin Drugs 0.000 title 1
- 206010003883 azoospermia Diseases 0.000 abstract 2
- 229940122878 Alpha 1 adrenoreceptor antagonist Drugs 0.000 abstract 1
- 230000037406 food intake Effects 0.000 abstract 1
- 230000003054 hormonal effect Effects 0.000 abstract 1
- 230000000977 initiatory effect Effects 0.000 abstract 1
- 208000008634 oligospermia Diseases 0.000 abstract 1
- 238000004806 packaging method and process Methods 0.000 abstract 1
- 230000002441 reversible effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
La présente invention concerne l'utilisation d'une composition dans un procédé de contraception non hormonale pour un sujet masculin, comprenant l'administration d'un antagoniste d'alpha-1-adrénorécepteur; le procédé de contraception comprenant une administration quotidienne unique de ladite composition environ au même moment chaque jour, le déclenchement d'une asperme réversible continue, d'une azoospermie ou d'une oligozoospermie sévère chez le sujet masculin, et, après une période initiale d'au moins deux jours consécutifs, la contraception n'est pas affectée par un retard de l'ingestion quotidienne unique suivante. La présente invention concerne également l'emballage comprenant 7, 14, 28, 56, 84 ou 168 à 365 doses unitaires; ou 10, 20, 30, 60, 90, ou 180 à 360 doses uniques de la composition à utiliser selon la présente invention.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18305328 | 2018-03-23 | ||
| PCT/EP2019/057267 WO2019180217A1 (fr) | 2018-03-23 | 2019-03-22 | Compositions non hormonales et procédés de contraception masculine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA47027B1 true MA47027B1 (fr) | 2020-08-31 |
Family
ID=61868479
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA47027A MA47027B1 (fr) | 2018-03-23 | 2019-03-22 | Compositions et procédés non hormonaux pour la contraception masculine avec (r)-silodosin |
Country Status (2)
| Country | Link |
|---|---|
| MA (1) | MA47027B1 (fr) |
| PT (1) | PT3750538T (fr) |
-
2019
- 2019-03-22 PT PT201826914T patent/PT3750538T/pt unknown
- 2019-03-22 MA MA47027A patent/MA47027B1/fr unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PT3750538T (pt) | 2024-10-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA43979B1 (fr) | Dérivés de 1h-indazole-3-carboxamide et composés similaires en tant qu'inhibiteurs du facteur d pour le traitement de maladies characterisés par une activité aberrante du système complémentaire, comme p.E. Troubles immunologiques | |
| JP2020172502A5 (fr) | ||
| WO2003105800A3 (fr) | Forme galenique, se presentant sous forme de film adherant a la muqueuse, pour l'administration de principes actifs du cannabis | |
| HRP20241461T1 (hr) | Aprocitentan za uporabu u liječenju hipertenzije i povezanih bolesti u kombinaciji s valsartanom | |
| MA43251B1 (fr) | Utilisation de dérivés d'indole n-substitués comme modulateurs des récepteurs des pge2 | |
| MA40768A (fr) | Dérivés d'indole mono ou di-substitué en tant qu'inhibiteurs de réplication du virus de la dengue | |
| MA26700A1 (fr) | FORMULATIONS PHARMACEUTIQUES D'INHIBITEURS DE PDE-5 DE GMPc à LIBERATION CONTROLEE, ET PROCEDE POUR LEUR PREPARATION. | |
| BR112022025381A2 (pt) | Métodos e composições para prevenir diabetes tipo 1 | |
| WO2021070200A3 (fr) | Compositions stables de (7as, 2's)-2-oxoclopidogrel et ses sels pharmaceutiques | |
| MA43913A (fr) | Modulateurs allostériques positifs du récepteur m1 muscarinique | |
| MA53626B1 (fr) | Procédés non hormonaux de contraception masculine avec (r)-silodosin | |
| HRP20231229T1 (hr) | Paradigma liječenja za protutijelo anti-cd19 i venetoklaks kombinacijsko liječenje | |
| CA2503211A1 (fr) | Composition pharmaceutique associant le tenatoprazole et un anti-inflammatoire | |
| MA47027B1 (fr) | Compositions et procédés non hormonaux pour la contraception masculine avec (r)-silodosin | |
| BR0308229A (pt) | Medicamentos contendo ingredientes ativos que diminuem o nìvel de colesterol com liberação do ingrediente ativo de tempo tardio | |
| Fenier et al. | Enalapril improved renal function and proteinuria in chronic glomerulopathies | |
| MA41174B1 (fr) | Dérivés d'imidazopyridazine utilisés en tant qu'inhibiteurs de pi3kbeta | |
| MX2021015727A (es) | Derivados de piridin-3-ilo. | |
| FR2399841A1 (fr) | Combinaison medicamenteuse antithrombotique et procede pour sa preparation | |
| IL273909B1 (en) | Treatment of cd20-positive b-cell lymphoma with obituzumab | |
| Mascolini | HIV prevention fails in all three VOICE arms, as daily Truvada PrEP falls | |
| KR950700064A (ko) | 장점막 장애 예방 및 치료제(agent for preventing and treat-ing disturbances of intestinal mucous membrane) | |
| WO2018220444A3 (fr) | Compositions et procédés de traitement du syndrome de la kératoconjonctivite sèche par administration d'un antibiotique macrolide | |
| KR870006035A (ko) | 신규 항균제 1-티에닐-4-옥소퀴놀린-3-카복실산 화합물의 제법 | |
| Lindsley | Pharmacotherapy of juvenile rheumatoid arthritis |